Abstract:
Regardless of the significant use of 5-bromo-20
-deoxyuridine (BrdU) as a radiosensitizer and diagnostic
tool in cancer patients, some severe side effects and health issues have been reported, such as genetic
mutations, birth defects, and other inheritable genetic effects. Thus, it has become more important to
quantify the amount of BrdU during its usage. With reference to this, Ni@4H-chromene (Ni@G1)-based
core–shell nanoparticles have been fabricated and these show a great response for the selective and
sensitive detection of BrdU. The formed Ni@G1 exhibits no significant response with interfering thymidine analogs like iododeoxyuridine (EI) and ethynyl deoxyuridine (EdU) in competitive binding studies.
Ni@G1 shows the ability to sense BrdU up to a detection limit of 9 nM and no significant interference is
shown by pH, salt and temperature. A comparison of studies in aqueous and organic media further
reveals that the sensor reported here shows an excellent response in an aqueous medium.
